NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE

NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE was reported 0 times

NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSTILLATION SITE DISCOLOURATION 2 0.0833
1 INSTILLATION SITE INFECTION 2 0.0426
2 INSTILLATION SITE PAIN 104 0.0419
3 LID MARGIN DISCHARGE 1 0.0370
4 MYDRIASIS 471 0.0367
5 CAPILLARY FRAGILITY INCREASED 1 0.0345
6 KALEIDOSCOPE VISION 1 0.0312
7 APPLICATION SITE ANAESTHESIA 2 0.0286
8 INSTILLATION SITE PARAESTHESIA 1 0.0238
9 CATARACT TRAUMATIC 1 0.0233
10 INSTILLATION SITE IRRITATION 26 0.0220
11 INSTILLATION SITE ERYTHEMA 11 0.0208
12 PINGUECULA 2 0.0189
13 EYES SUNKEN 1 0.0182
14 INSTILLATION SITE INFLAMMATION 1 0.0179
15 INSTILLATION SITE SWELLING 3 0.0171
16 DRUG LABEL CONFUSION 4 0.0160
17 CONJUNCTIVAL CYST 1 0.0156
18 CONGENITAL ACROCHORDON 1 0.0154
19 WRONG PRODUCT PROCURED 1 0.0152
20 INSTILLATION SITE DISCOMFORT 2 0.0149
21 CHEMICAL BURNS OF EYE 4 0.0144
22 LID LAG 1 0.0143
23 INSTILLATION SITE FOREIGN BODY SENSATION 2 0.0138
24 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
25 SCLERAL OEDEMA 1 0.0120
26 PRODUCT STERILITY LACKING 1 0.0119
27 CHEMICAL EYE INJURY 1 0.0102
28 EYELID RETRACTION 1 0.0100
29 IRIS HYPERPIGMENTATION 2 0.0096
30 IRIS HYPOPIGMENTATION 1 0.0093
31 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
32 MIDDLE EAR DISORDER 1 0.0092
33 EYE IRRITATION 490 0.0085
34 HYPOAESTHESIA EYE 5 0.0085
35 INSTILLATION SITE LACRIMATION 2 0.0083
36 INSTILLATION SITE PRURITUS 3 0.0080
37 ANISOCORIA 3 0.0079
38 EYE PARAESTHESIA 1 0.0064
39 HALO VISION 7 0.0062
40 URINARY RETENTION POSTOPERATIVE 1 0.0061
41 PRODUCT CLOSURE REMOVAL DIFFICULT 6 0.0059
42 SUPERFICIAL INJURY OF EYE 6 0.0055
43 EXPIRED DRUG ADMINISTERED 27 0.0055
44 EYELID SENSORY DISORDER 1 0.0051
45 REACTION TO PRESERVATIVES 4 0.0049
46 PERIORBITAL DISORDER 1 0.0049
47 ABNORMAL SENSATION IN EYE 20 0.0046
48 ANTERIOR CHAMBER FLARE 1 0.0043
49 GLARE 2 0.0039
50 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 2 0.0038
51 INSTILLATION SITE DISCHARGE 1 0.0038
52 DEPOSIT EYE 1 0.0037
53 SCLERAL DISORDER 1 0.0037
54 OCULAR HYPERAEMIA 172 0.0036
55 POIKILOCYTOSIS 1 0.0036
56 FOREIGN BODY SENSATION IN EYES 23 0.0036
57 PRODUCT CLOSURE ISSUE 2 0.0036
58 EYELID THICKENING 1 0.0035
59 EYELID MARGIN CRUSTING 10 0.0035
60 EYE PAIN 191 0.0034
61 EYELIDS PRURITUS 10 0.0032
62 BENIGN OVARIAN TUMOUR 1 0.0031
63 FOREIGN BODY IN EYE 3 0.0031
64 PATIENT DISSATISFACTION WITH TREATMENT 6 0.0031
65 SCLERAL DISCOLOURATION 2 0.0030
66 GASTROINTESTINAL POLYP 1 0.0030
67 METASTATIC GASTRIC CANCER 1 0.0029
68 PTERYGIUM 1 0.0029
69 KERATOCONJUNCTIVITIS SICCA 1 0.0027
70 PUPILS UNEQUAL 3 0.0026
71 EYELID DISORDER 6 0.0026
72 EYELID EXFOLIATION 2 0.0025
73 EYELID SKIN DRYNESS 3 0.0025
74 EYELID PAIN 5 0.0025
75 ERYTHEMA OF EYELID 13 0.0024
76 EYELID IRRITATION 6 0.0024
77 EYE DISCHARGE 24 0.0023
78 PUPIL FIXED 4 0.0023
79 EYE PRURITUS 77 0.0023
80 ENLARGED UVULA 1 0.0022
81 LACRIMATION INCREASED 67 0.0022
82 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
83 IMPLANT SITE REACTION 1 0.0022
84 SICKLE CELL DISEASE 1 0.0022
85 KERATIC PRECIPITATES 1 0.0021
86 DRAINAGE 1 0.0020
87 INTRAOCULAR LENS IMPLANT 1 0.0020
88 ASTHENOPIA 11 0.0020
89 EYELID OEDEMA 23 0.0020
90 OCULAR DISCOMFORT 22 0.0020
91 IRIS ADHESIONS 1 0.0019
92 EYE ALLERGY 3 0.0019
93 INJURY CORNEAL 1 0.0019
94 BLOOD PH INCREASED 1 0.0018
95 PRODUCT PACKAGE ASSOCIATED INJURY 4 0.0018
96 EYE INFECTION BACTERIAL 1 0.0018
97 NAIL DYSTROPHY 1 0.0018
98 URINE COLOUR ABNORMAL 1 0.0018
99 PHOTOPHOBIA 33 0.0018
100 SENSITIVITY OF TEETH 3 0.0017
101 LACRIMAL DISORDER 1 0.0017
102 VISION BLURRED 234 0.0017
103 EYE BURNS 1 0.0017
104 AMBLYOPIA 1 0.0017
105 WRONG DRUG ADMINISTERED 15 0.0017
106 METAMORPHOPSIA 3 0.0016
107 PERIORBITAL SWELLING 9 0.0016
108 PAROTID GLAND ENLARGEMENT 1 0.0015
109 ANISOCYTOSIS 1 0.0015
110 CORNEAL ABRASION 2 0.0015
111 EYE SWELLING 54 0.0015
112 INGROWN HAIR 1 0.0014
113 EXPIRED PRODUCT ADMINISTERED 48 0.0014
114 PULMONARY VENO-OCCLUSIVE DISEASE 1 0.0014
115 GLASSY EYES 1 0.0014
116 TRYPTASE INCREASED 1 0.0014
117 DYSHIDROTIC ECZEMA 1 0.0014
118 RETINAL VASCULAR OCCLUSION 1 0.0014
119 CHLAMYDIAL INFECTION 1 0.0013
120 CHROMATOPSIA 1 0.0013
121 DIARRHOEA INFECTIOUS 1 0.0013
122 CHEMICAL INJURY 1 0.0012
123 LABYRINTHITIS 3 0.0012
124 PERIORBITAL PAIN 1 0.0012
125 ENDOCRINE OPHTHALMOPATHY 1 0.0012
126 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
127 VASOCONSTRICTION 1 0.0011
128 PERIPHERAL NERVE INJURY 1 0.0011
129 TRANSFUSION REACTION 1 0.0011
130 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1 0.0011
131 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
132 EYELID RASH 1 0.0010
133 BLEPHARITIS 4 0.0010
134 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
135 BREAST ABSCESS 1 0.0010
136 CONJUNCTIVAL OEDEMA 1 0.0010
137 DRY EYE 48 0.0010
138 CONSCIOUSNESS FLUCTUATING 1 0.0010
139 HORDEOLUM 4 0.0009
140 VITREOUS DETACHMENT 2 0.0009
141 INSTILLATION SITE REACTION 1 0.0009
142 STRESS AT WORK 1 0.0009
143 MACROCYTOSIS 1 0.0009
144 NECK SURGERY 2 0.0009
145 OTITIS EXTERNA 1 0.0008
146 PALATAL OEDEMA 1 0.0008
147 BLEPHAROSPASM 5 0.0008
148 EYE INFECTION 8 0.0007
149 CHORIORETINOPATHY 1 0.0007
150 DRUG ADMINISTRATION ERROR 21 0.0007
151 DARK CIRCLES UNDER EYES 1 0.0007
152 PRECANCEROUS SKIN LESION 1 0.0007
153 ASTIGMATISM 1 0.0007
154 IRITIS 2 0.0007
155 HEAT STROKE 1 0.0007
156 IRIDOCYCLITIS 2 0.0006
157 NIGHT BLINDNESS 1 0.0006
158 WRONG PRODUCT ADMINISTERED 4 0.0006
159 PRODUCT CONTAINER ISSUE 5 0.0006
160 INCORRECT STORAGE OF DRUG 1 0.0006
161 RECALLED PRODUCT 1 0.0006
162 SPINAL CORD INJURY 1 0.0006
163 INFUSION SITE DISCHARGE 1 0.0006
164 TERMINAL INSOMNIA 1 0.0006
165 PRODUCT CONTAMINATION 2 0.0006
166 PRODUCT TAMPERING 1 0.0006
167 BLINDNESS TRANSIENT 4 0.0005
168 BURNING SENSATION 38 0.0005
169 AURA 1 0.0005
170 EYE INFLAMMATION 5 0.0005
171 GINGIVAL RECESSION 1 0.0005
172 OCULAR HYPERTENSION 1 0.0005
173 PURULENCE 1 0.0005
174 HYPERAEMIA 1 0.0005
175 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
176 CARDIAC DISCOMFORT 1 0.0005
177 SEASONAL ALLERGY 7 0.0005
178 EAR HAEMORRHAGE 1 0.0005
179 SWELLING OF EYELID 3 0.0005
180 PHOTOPSIA 3 0.0005
181 EXOPHTHALMOS 1 0.0005
182 OCULAR ICTERUS 2 0.0005
183 CORNEAL DISORDER 1 0.0005
184 PRODUCT LOT NUMBER ISSUE 1 0.0005
185 CORNEAL OEDEMA 1 0.0004
186 EYE DISORDER 14 0.0004
187 URINARY TRACT OBSTRUCTION 1 0.0004
188 WRONG DOSE 1 0.0004
189 DERMAL CYST 1 0.0004
190 PROTEIN URINE PRESENT 2 0.0004
191 RETINAL ARTERY OCCLUSION 1 0.0004
192 CHEMICAL BURN OF SKIN 1 0.0004
193 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
194 ANGLE CLOSURE GLAUCOMA 1 0.0004
195 MEDICATION RESIDUE 1 0.0004
196 VISUAL IMPAIRMENT 48 0.0004
197 RETINAL DISORDER 1 0.0004
198 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
199 BLOOD POTASSIUM ABNORMAL 1 0.0004
200 PRODUCT DELIVERY MECHANISM ISSUE 2 0.0004
201 EAR CONGESTION 1 0.0004
202 PRODUCT QUALITY ISSUE 50 0.0004
203 NORMAL NEWBORN 2 0.0004
204 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
205 MEDICATION ERROR 20 0.0004
206 HEART VALVE INCOMPETENCE 1 0.0003
207 PARAPLEGIA 1 0.0003
208 HYPERTONIC BLADDER 1 0.0003
209 STRABISMUS 1 0.0003
210 CATARACT OPERATION 2 0.0003
211 SYMPTOM RECURRENCE 2 0.0003
212 ENDOPHTHALMITIS 2 0.0003
213 EYE INJURY 1 0.0003
214 PROSTATITIS 1 0.0003
215 BLOOD BLISTER 1 0.0003
216 DRUG EFFECT INCREASED 1 0.0003
217 BLADDER PAIN 1 0.0003
218 INTRAOCULAR PRESSURE INCREASED 4 0.0003
219 DIPLOPIA 8 0.0003
220 VITREOUS FLOATERS 3 0.0003
221 DEAFNESS NEUROSENSORY 1 0.0003
222 PHOTOSENSITIVITY REACTION 5 0.0003
223 SKIN INJURY 1 0.0003
224 PEPTIC ULCER 1 0.0003
225 SINUS CONGESTION 4 0.0003
226 PRODUCT LABEL ISSUE 2 0.0003
227 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
228 EAR DISCOMFORT 3 0.0003
229 APHONIA 4 0.0003
230 EAR PRURITUS 1 0.0003
231 VISUAL FIELD DEFECT 2 0.0003
232 SKIN LACERATION 3 0.0003
233 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
234 VISUAL ACUITY REDUCED 9 0.0003
235 CONJUNCTIVITIS 5 0.0003
236 CHRONIC SINUSITIS 1 0.0003
237 PARANASAL SINUS HYPERSECRETION 1 0.0003
238 PROCEDURAL HAEMORRHAGE 1 0.0003
239 MULTIPLE ALLERGIES 2 0.0003
240 DRUG INEFFECTIVE 333 0.0003
241 CONDITION AGGRAVATED 76 0.0002
242 MIOSIS 2 0.0002
243 GALLBLADDER OPERATION 1 0.0002
244 ACCIDENTAL EXPOSURE 1 0.0002
245 PURULENT DISCHARGE 1 0.0002
246 METASTATIC NEOPLASM 1 0.0002
247 ADVERSE REACTION 3 0.0002
248 EYE HAEMORRHAGE 3 0.0002
249 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
250 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
251 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
252 EAR DISORDER 1 0.0002
253 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
254 DIZZINESS POSTURAL 2 0.0002
255 DRUG EFFECT DECREASED 11 0.0002
256 HOSPICE CARE 2 0.0002
257 HYPERVOLAEMIA 1 0.0002
258 PRODUCT COLOUR ISSUE 1 0.0002
259 VARICOSE VEIN 1 0.0002
260 STOMACH DISCOMFORT 1 0.0002
261 SENSITIVITY TO WEATHER CHANGE 1 0.0002
262 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
263 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
264 NYSTAGMUS 1 0.0002
265 BODY HEIGHT DECREASED 2 0.0002
266 INJECTION SITE DISCHARGE 1 0.0002
267 PRODUCT RESIDUE PRESENT 1 0.0002
268 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
269 APPLICATION SITE PAIN 4 0.0002
270 PRODUCT LEAKAGE 1 0.0002
271 HEART RATE IRREGULAR 4 0.0002
272 REBOUND EFFECT 2 0.0002
273 EXERCISE TOLERANCE DECREASED 1 0.0002
274 MADAROSIS 2 0.0002
275 MACULAR DEGENERATION 2 0.0002
276 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
277 PIGMENTATION DISORDER 1 0.0002
278 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
279 APPLICATION SITE IRRITATION 2 0.0002
280 THERAPEUTIC RESPONSE CHANGED 1 0.0002
281 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
282 GLAUCOMA 3 0.0002
283 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
284 ORAL HERPES 3 0.0002
285 RESPIRATORY TRACT INFECTION 4 0.0002
286 PRODUCT FORMULATION ISSUE 1 0.0002
287 CORONAVIRUS INFECTION 1 0.0002
288 MENINGITIS 1 0.0001
289 COLITIS ISCHAEMIC 1 0.0001
290 PRODUCT TASTE ABNORMAL 2 0.0001
291 GINGIVAL BLEEDING 2 0.0001
292 HAIR GROWTH ABNORMAL 1 0.0001
293 FORMICATION 1 0.0001
294 BLINDNESS UNILATERAL 2 0.0001
295 SWELLING FACE 9 0.0001
296 FLUID OVERLOAD 2 0.0001
297 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
298 MOUTH HAEMORRHAGE 1 0.0001
299 SENSITIVE SKIN 1 0.0001
300 ARTHROPOD BITE 1 0.0001
301 SNEEZING 3 0.0001
302 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
303 BREAST TENDERNESS 1 0.0001
304 PAROSMIA 1 0.0001
305 DISCOMFORT 8 0.0001
306 ATRIOVENTRICULAR BLOCK 1 0.0001
307 APHTHOUS ULCER 1 0.0001
308 THERAPY PARTIAL RESPONDER 2 0.0001
309 DRUG SCREEN POSITIVE 1 0.0001
310 HYPERSENSITIVITY 23 0.0001
311 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
312 HEMIPLEGIA 1 0.0001
313 SENSATION OF FOREIGN BODY 1 0.0001
314 SKIN PLAQUE 1 0.0001
315 PRODUCT COMPLAINT 3 0.0001
316 UTERINE PERFORATION 1 0.0001
317 VITAMIN D DECREASED 1 0.0001
318 SKIN HYPERPIGMENTATION 1 0.0001
319 PSYCHOLOGICAL TRAUMA 1 0.0001
320 HYSTERECTOMY 1 0.0001
321 VERTIGO 7 0.0001
322 URINE OUTPUT DECREASED 1 0.0001
323 HAEMOLYTIC ANAEMIA 1 0.0001
324 GASTROINTESTINAL INFECTION 1 0.0001
325 GASTROENTERITIS VIRAL 2 0.0001
326 LIMB INJURY 3 0.0001
327 BRAIN NEOPLASM 1 0.0001
328 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
329 APPENDICITIS 1 0.0001
330 BLISTER 6 0.0001
331 PRODUCT PACKAGING ISSUE 1 0.0001
332 RECALLED PRODUCT ADMINISTERED 1 0.0001
333 BALANCE DISORDER 9 0.0001
334 ACUTE RESPIRATORY FAILURE 2 0.0001
335 AUTOIMMUNE DISORDER 1 0.0001
336 SKIN FISSURES 2 0.0001
337 PHARYNGEAL SWELLING 1 0.0001
338 ERYTHEMA 21 0.0001
339 LIGAMENT SPRAIN 1 0.0001
340 BLOOD PRESSURE ABNORMAL 2 0.0001
341 BRAIN INJURY 1 0.0001
342 POOR QUALITY DEVICE USED 1 0.0001
343 HYPOTHERMIA 1 0.0001
344 ILL-DEFINED DISORDER 6 0.0001
345 EYELID PTOSIS 1 0.0001
346 BLOOD PRESSURE INCREASED 15 0.0001
347 WEIGHT FLUCTUATION 1 0.0001
348 SCRATCH 1 0.0001
349 IMPAIRED WORK ABILITY 2 0.0001
350 POOR QUALITY SLEEP 2 0.0001
351 RHINORRHOEA 6 0.0001
352 PRURITUS GENERALISED 2 0.0001
353 PHARYNGITIS STREPTOCOCCAL 1 0.0001
354 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
355 DENTAL CARIES 1 0.0001
356 VIRAL INFECTION 3 0.0001
357 APPLICATION SITE PRURITUS 2 0.0001
358 IMPAIRED DRIVING ABILITY 1 0.0001
359 DERMATITIS CONTACT 1 0.0001
360 INCORRECT DOSE ADMINISTERED 20 0.0001
361 MICTURITION URGENCY 1 0.0001
362 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
363 TINNITUS 4 0.0001
364 RASH MACULAR 3 0.0001
365 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
366 PANIC ATTACK 3 0.0001
367 DYSURIA 3 0.0001
368 MUSCLE SPASTICITY 1 0.0001
369 CARDIOMEGALY 1 0.0001
370 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
371 HEADACHE 50 0.0001
372 DERMATITIS ALLERGIC 1 0.0001
373 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
374 INJECTION SITE IRRITATION 1 0.0001
375 DIZZINESS 39 0.0001
376 SINUSITIS 8 0.0001
377 THERAPY CESSATION 4 0.0001
378 EXPOSURE VIA SKIN CONTACT 2 0.0001
379 INJECTION SITE INDURATION 1 0.0001
380 NODULE 1 0.0001
381 INCORRECT PRODUCT STORAGE 1 0.0001
382 BEDRIDDEN 1 0.0001
383 HAIR TEXTURE ABNORMAL 1 0.0001
384 FEAR 2 0.0001
385 TREATMENT NONCOMPLIANCE 4 0.0001
386 ABNORMAL DREAMS 2 0.0001
387 HUNGER 1 0.0001
388 INFLUENZA 8 0.0001
389 CARPAL TUNNEL SYNDROME 1 0.0001
390 LYMPHOPENIA 1 0.0001
391 PRURITUS 27 0.0001
392 HYPERSOMNIA 2 0.0001
393 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
394 DYSSTASIA 2 0.0001
395 DRY SKIN 9 0.0001
396 FEELING ABNORMAL 16 0.0001
397 HOT FLUSH 5 0.0001
398 INSURANCE ISSUE 1 0.0001
399 LYMPHOMA 1 0.0001
400 LUNG INFECTION 1 0.0001
401 SWELLING 6 0.0001
402 BASAL CELL CARCINOMA 1 0.0001
403 PRODUCT USE COMPLAINT 1 0.0001
404 ULCER 1 0.0001
405 MIGRAINE 6 0.0001
406 RASH ERYTHEMATOUS 3 0.0001
407 SCIATICA 1 0.0001
408 SENSORY DISTURBANCE 1 0.0001
409 METASTASES TO BONE 1 0.0001
410 FUNGAL INFECTION 2 0.0001
411 SKIN EXFOLIATION 5 0.0001
412 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
413 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
414 ILLNESS 6 0.0001
415 MUSCULOSKELETAL DISCOMFORT 1 0.0001
416 PARANOIA 1 0.0001
417 ECZEMA 3 0.0001
418 INTENTIONAL PRODUCT MISUSE 5 0.0001
419 PAIN 35 0.0001
420 COLD SWEAT 1 0.0001
421 TOOTHACHE 1 0.0001
422 DRUG EFFECT INCOMPLETE 2 0.0001
423 HYPERHIDROSIS 7 0.0001
424 DYSGEUSIA 4 0.0001
425 HEPATIC STEATOSIS 1 0.0001
426 THINKING ABNORMAL 1 0.0001
427 EPISTAXIS 4 0.0001
428 FLATULENCE 3 0.0001
429 COLITIS 2 0.0001
430 BLOOD URINE PRESENT 1 0.0001
431 FEELING JITTERY 1 0.0001
432 CONTUSION 5 0.0001
433 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
434 DISABILITY 1 0.0001
435 DISORIENTATION 2 0.0001
436 HEART RATE INCREASED 5 0.0001
437 CATARACT 3 0.0001
438 SPINAL FRACTURE 1 0.0000
439 FEEDING DISORDER 1 0.0000
440 DRY MOUTH 4 0.0000
441 PSORIATIC ARTHROPATHY 2 0.0000
442 BLINDNESS 2 0.0000
443 INJECTION SITE WARMTH 1 0.0000
444 OFF LABEL USE 42 0.0000
445 POLLAKIURIA 2 0.0000
446 URTICARIA 8 0.0000
447 DERMATITIS 1 0.0000
448 EATING DISORDER 1 0.0000
449 JOINT INJURY 1 0.0000
450 IRRITABLE BOWEL SYNDROME 1 0.0000
451 HYPOACUSIS 2 0.0000
452 FAECES DISCOLOURED 1 0.0000
453 PRODUCT DISPENSING ERROR 1 0.0000
454 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
455 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
456 INSOMNIA 12 0.0000
457 TOOTH DISORDER 1 0.0000
458 ORAL PAIN 1 0.0000
459 THERAPY NON-RESPONDER 2 0.0000
460 CHROMATURIA 1 0.0000
461 PRODUCT AVAILABILITY ISSUE 1 0.0000
462 SKIN DISCOLOURATION 2 0.0000
463 RENAL DISORDER 2 0.0000
464 COGNITIVE DISORDER 2 0.0000
465 SKIN BURNING SENSATION 3 0.0000
466 BLOOD PRESSURE FLUCTUATION 1 0.0000
467 LOCALISED INFECTION 1 0.0000
468 PRESYNCOPE 1 0.0000
469 DYSPEPSIA 4 0.0000
470 FLUID RETENTION 2 0.0000
471 HEPATITIS 1 0.0000
472 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
473 INFLAMMATION 2 0.0000
474 UNRESPONSIVE TO STIMULI 1 0.0000
475 SKIN ULCER 1 0.0000
476 NO ADVERSE EVENT 7 0.0000
477 APPLICATION SITE ERYTHEMA 1 0.0000
478 NASOPHARYNGITIS 7 0.0000
479 DERMATITIS ATOPIC 2 0.0000
480 EAR INFECTION 1 0.0000
481 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
482 PAIN OF SKIN 1 0.0000
483 CONFUSIONAL STATE 6 0.0000
484 DISTURBANCE IN ATTENTION 2 0.0000
485 FREQUENT BOWEL MOVEMENTS 1 0.0000
486 THROAT TIGHTNESS 1 0.0000
487 PALLOR 1 0.0000
488 RESPIRATORY ARREST 1 0.0000
489 TREMOR 6 0.0000
490 HAEMOPTYSIS 1 0.0000
491 NECK PAIN 2 0.0000
492 DEMENTIA 1 0.0000
493 WOUND 1 0.0000
494 ABDOMINAL DISCOMFORT 6 0.0000
495 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
496 INTENTIONAL DOSE OMISSION 1 0.0000
497 DYSPHONIA 2 0.0000
498 PALPITATIONS 4 0.0000
499 NASAL CONGESTION 2 0.0000
500 WHEEZING 2 0.0000
501 HYPOAESTHESIA 5 0.0000
502 APHASIA 1 0.0000
503 THERAPEUTIC RESPONSE DECREASED 2 0.0000
504 OEDEMA PERIPHERAL 4 0.0000
505 FEELING HOT 2 0.0000
506 ADVERSE EVENT 3 0.0000
507 EMOTIONAL DISORDER 1 0.0000
508 LIMB DISCOMFORT 1 0.0000
509 SWOLLEN TONGUE 1 0.0000
510 ANXIETY 9 0.0000
511 PRODUCT DOSE OMISSION 2 0.0000
512 PAIN IN EXTREMITY 9 0.0000
513 INFUSION RELATED REACTION 2 0.0000
514 LIP SWELLING 1 0.0000
515 URINARY RETENTION 1 0.0000
516 GAIT INABILITY 1 0.0000
517 INJECTION SITE PRURITUS 2 0.0000
518 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
519 MYALGIA 5 0.0000
520 MEMORY IMPAIRMENT 4 0.0000
521 DEVICE USE ERROR 1 0.0000
522 HAEMORRHAGE 3 0.0000
523 WEIGHT DECREASED 8 0.0000
524 COUGH 8 0.0000
525 HEART RATE DECREASED 1 0.0000
526 INJURY 2 0.0000
527 SLEEP DISORDER 2 0.0000
528 FATIGUE 22 0.0000
529 LYMPHADENOPATHY 1 0.0000
530 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
531 DIARRHOEA 18 0.0000
532 NAUSEA 22 0.0000
533 CRYING 1 0.0000
534 PRODUCT USE ISSUE 5 0.0000
535 DYSARTHRIA 1 0.0000
536 DYSPNOEA EXERTIONAL 1 0.0000
537 INTESTINAL OBSTRUCTION 1 0.0000
538 ACNE 2 0.0000
539 GAIT DISTURBANCE 5 0.0000
540 ARTHRITIS 2 0.0000
541 PARAESTHESIA 4 0.0000
542 RASH 11 0.0000
543 JOINT SWELLING 3 0.0000
544 EMOTIONAL DISTRESS 3 0.0000
545 EXTRA DOSE ADMINISTERED 1 0.0000
546 DEVICE BREAKAGE 1 0.0000
547 NEUTROPHIL COUNT DECREASED 1 0.0000
548 OSTEOPOROSIS 1 0.0000
549 ABDOMINAL PAIN UPPER 5 0.0000
550 TREATMENT FAILURE 2 0.0000
551 CARDIO-RESPIRATORY ARREST 1 0.0000
552 RECTAL HAEMORRHAGE 1 0.0000
553 SEPTIC SHOCK 1 0.0000
554 PULMONARY OEDEMA 1 0.0000
555 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
556 THROAT IRRITATION 1 0.0000
557 ADVERSE DRUG REACTION 2 0.0000
558 SUICIDAL IDEATION 2 0.0000
559 SKIN IRRITATION 1 0.0000
560 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
561 BLOOD GLUCOSE INCREASED 4 0.0000
562 DYSPNOEA 12 0.0000
563 NEUROPATHY PERIPHERAL 2 0.0000
564 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
565 INFECTION 3 0.0000
566 ATRIAL FIBRILLATION 2 0.0000
567 PRODUCT DOSE OMISSION ISSUE 6 0.0000
568 LEUKOPENIA 1 0.0000
569 SYNCOPE 2 0.0000
570 SOMNOLENCE 4 0.0000
571 FLUSHING 2 0.0000
572 CHEST DISCOMFORT 2 0.0000
573 HOSPITALISATION 3 0.0000
574 HAEMOGLOBIN DECREASED 2 0.0000
575 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
576 VOMITING 9 0.0000
577 NERVOUSNESS 1 0.0000
578 MUSCULOSKELETAL PAIN 1 0.0000
579 SPEECH DISORDER 1 0.0000
580 DEPRESSED MOOD 1 0.0000
581 RASH PRURITIC 1 0.0000
582 OEDEMA 1 0.0000
583 ANAPHYLACTIC REACTION 1 0.0000
584 OXYGEN SATURATION DECREASED 1 0.0000
585 ASTHMA 2 0.0000
586 MUSCULAR WEAKNESS 2 0.0000
587 HERPES ZOSTER 1 0.0000
588 LETHARGY 1 0.0000
589 COVID-19 3 0.0000
590 IRRITABILITY 1 0.0000
591 CHEST PAIN 3 0.0000
592 INJECTION SITE ERYTHEMA 2 0.0000
593 AMNESIA 1 0.0000
594 BLOOD CREATININE INCREASED 1 0.0000
595 BLOOD PRESSURE DECREASED 1 0.0000
596 FALL 5 0.0000
597 HEPATIC ENZYME INCREASED 1 0.0000
598 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
599 ARTHRALGIA 6 0.0000
600 HYPERTENSION 3 0.0000
601 THERAPY INTERRUPTED 1 0.0000
602 MOBILITY DECREASED 1 0.0000
603 AGITATION 1 0.0000
604 BRONCHITIS 1 0.0000
605 UNEVALUABLE EVENT 1 0.0000
606 DIABETES MELLITUS 1 0.0000
607 INJECTION SITE SWELLING 1 0.0000
608 DECREASED APPETITE 3 0.0000
609 BACK PAIN 3 0.0000
610 ABDOMINAL PAIN 3 0.0000
611 CARDIAC FAILURE 1 0.0000
612 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
613 INFLUENZA LIKE ILLNESS 1 0.0000
614 CEREBROVASCULAR ACCIDENT 2 0.0000
615 DRUG WITHDRAWAL SYNDROME 1 0.0000
616 TACHYCARDIA 1 0.0000
617 GASTROINTESTINAL DISORDER 1 0.0000
618 MUSCLE SPASMS 2 0.0000
619 ASTHENIA 4 0.0000
620 DYSPHAGIA 1 0.0000
621 ALOPECIA 2 0.0000
622 HYPOTENSION 2 0.0000
623 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
624 OVERDOSE 2 0.0000
625 PNEUMONIA 3 0.0000
626 CONSTIPATION 2 0.0000
627 SEPSIS 1 0.0000
628 WEIGHT INCREASED 2 0.0000
629 DEPRESSION 2 0.0000
630 SEIZURE 1 0.0000
631 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
632 DISEASE PROGRESSION 1 0.0000
633 LOSS OF CONSCIOUSNESS 1 0.0000
634 PSORIASIS 1 0.0000
635 DEHYDRATION 1 0.0000
636 NEUTROPENIA 1 0.0000
637 MALAISE 3 0.0000
638 ACUTE KIDNEY INJURY 1 0.0000
639 INJECTION SITE PAIN 2 0.0000
640 PERIPHERAL SWELLING 1 0.0000
641 DRUG DOSE OMISSION 1 0.0000
642 TOXICITY TO VARIOUS AGENTS 1 0.0000
643 URINARY TRACT INFECTION 1 0.0000
644 PYREXIA 2 0.0000
645 MYOCARDIAL INFARCTION 1 0.0000
646 ANAEMIA 1 0.0000
647 DEATH 4 0.0000